Skip to main content
This site uses cookies as described in our Cookie Policy. If you agree to our use of cookies, please continue to use our site.
 
VISIT JANSSEN GLOBAL
 
 
 

EMEA
change location▼

Search
Search

Welcome to Janssen Europe, Middle-East and Africa

VISIT JANSSEN GLOBAL

Janssen EMEA › Media Center

Media Center

The Media Center is intented to provide resources for media professionals only. It is not inteded for use by healthcare professionals, patients or the general public. To access, please confirm that you are an accredited member of the press. I hereby confirm that I am an accredited member of the press
I Agree
Cancel

Press Releases

Jun 19, 2018

Janssen Phase 3 Study Programme of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Presented for the First Time in Europe

Jun 13, 2018

Imbruvica ®▼ (ibrutinib) in Combination with Rituximab Showed Greater Efficacy Compared to Placebo Plus Rituximab in Patients with Waldenström’s Macroglobulinemia, a Rare and Incurable Form of NonHodgkin’s Lymphomae

Jun 13, 2018

Erdafitinib Phase 2 Study Results Show Promise in the Treatment of Metastatic Urothelial Cancer

May 22, 2018

Janssen Announces European Commission Approval of JULUCA®▼ (dolutegravir/rilpivirine), the First Two-Drug Regimen, OnceDaily, Single-Pill for the Treatment of HIV-1

May 18, 2018

Janssen to Present New Data in Urothelial, Haematologic and Prostate Cancers at ASCO 2018, including Best of ASCO Selections

May 17, 2018

Janssen ASCO 2018 List of Abstracts

View more Press Releases

Media Backgrounders

Waldenström’s Macroglobulinemia (WM)

The Role Of The Immune System In Crohn’s Disease

Stelara MOA infographic

About Crohn’s Disease Backgrounder

Mantle Cell Lymphoma (MCL)

Multiple Myeloma (MM)

VIEW MORE MEDIA BACKGROUNDERS

Quick Links

 

Tweets

 
Follow us on Twitter
SUBSCRIBE TO OUR YOUTUBE CHANNEL

Events

View more events